How much does tirzepatide actually cost? A global price survey for 2026

The cheapest legal tirzepatide on the planet is about 180 USD per month. The most expensive is about 1,350 USD per month. The molecule is identical. The difference is geography, distribution, and whether a pharmacy benefit manager is between you and the vial.

Here is what a typical monthly cost looks like across 10 markets in April 2026, how to arbitrage them, and what the tradeoffs are.

The table

Numbers below are midpoint USD equivalents for a 5-10 mg per week protocol. Actual cost varies with dose, consultation, and bundled services.

| Market | Channel | Monthly USD | |---|---|---| | Thailand | Direct vendor, research-grade | $80 to $220 | | Thailand | Bangkok clinic, brand Mounjaro | $180 to $450 | | India | Private prescription, where available | $250 to $400 | | US | 503A compounded, telehealth | $250 to $500 | | Mexico | Private prescription, clinic | $300 to $600 | | Spain | Private prescription | $400 to $800 | | Portugal | Private prescription | $400 to $800 | | Denmark | Private prescription | $400 to $800 | | UK | Private Rx (Boots, Pharmacy2U) | $450 to $900 | | Sweden | Private prescription | $450 to $900 | | France | Private prescription | $500 to $950 | | Italy | Private prescription | $500 to $900 | | Germany | Private prescription | $500 to $950 | | Australia | Private Rx | $550 to $1,000 | | Singapore | Private Rx | $600 to $1,050 | | Japan | Private clinic | $600 to $1,100 | | Norway | Private Rx, domestic apotek | $600 to $1,100 | | US | Brand Zepbound or Mounjaro | $1,000 to $1,350 |

The five patterns

Pattern 1: Thailand is the global low. Bangkok clinics and vetted direct vendors consistently offer the lowest legitimate pricing. This is not a marketing claim; it is a function of (a) Thai FDA allowing private clinic import of Lilly brand product without heavy reimbursement bureaucracy, and (b) a domestic compounding/research-chem industry operating at scale.

Pattern 2: Europe sits in the middle. EU member states broadly price tirzepatide between 400 and 1,000 USD monthly on private prescription. National health systems rarely cover weight-only indications; diabetes coverage is inconsistent. Cross-border EEA prescription validity creates real arbitrage between Denmark/Sweden (cheaper) and Norway/Finland (more expensive).

Pattern 3: The US is a three-tier market. Brand at 1,000-1,350/month is what you pay through traditional pharmacy without insurance. Compounded at 250-500 is what telehealth services (Ro, Henry, Mochi, LifeMD) charge for 503A-compounded product. Insurance-covered at $25-50 copay exists for the small slice of patients whose employer plan covers Zepbound or Wegovy. Whether your plan does is a coin flip.

Pattern 4: Japan and Singapore are expensive. Both have strict health product regulation, limited compounding, and concierge-priced private clinic channels. Not good arbitrage targets.

Pattern 5: Mexico is underpriced relative to its health system. 300-600 USD monthly in urban Mexico is achievable through private clinics. Growing expat-pharmacy channel. Not yet mainstream but worth watching.

How the arbitrage actually works

Three strategies people use:

The Thailand trip. Fly to Bangkok, book a private clinic consultation (typically 1,500 to 3,000 THB), walk out with a 3-month supply. Net cost of 3 months tirzepatide plus flights, hotel, and clinic visit: often competitive with 3 months of domestic US prescription for someone paying cash. More compelling if you build the trip around other things.

The EU cross-border. Get a prescription from a Danish or Swedish online clinic. Dispense at your home country apotek if allowed. Works most reliably for Norwegian residents (EEA directive 2011/24 validity), less reliably for non-EU countries like the UK post-Brexit.

The US compounded telehealth. Best-case domestic option. Quality depends entirely on the pharmacy partner (see our compounded vs brand post for the 5 questions to ask). At roughly 250-500 USD/mo, it is about 75% cheaper than brand and widely accessible.

The 90-day total view

For someone targeting 10 mg weekly after a standard ramp, the first 90-day total cost looks like:

Thailand clinic (brand): ~$500-$1,000 total Thailand direct (research-grade): ~$250-$600 total US compounded: ~$900-$1,500 total US brand cash: ~$3,300-$4,100 total UK private Rx: ~$1,500-$2,800 total Germany private Rx: ~$1,700-$3,000 total

If the 90-day spread between Thailand and US is roughly 2,500-3,500 USD, and a flight to Bangkok is 800-1,500 USD from the US or EU, the math gets interesting.

The long-term view

Tirzepatide is a maintenance drug. You will likely be on it for years, not months. At US brand pricing that is 12-16k USD per year indefinitely. At Thailand clinic pricing that is 3-5k USD per year. The annual compound is the number that matters.

For most US patients, the compounded route at 250-500/mo is the practical choice. For anyone with the flexibility to travel, Thailand becomes a viable annual supply strategy. For Europeans, cross-border EEA prescription arbitrage cuts 30-40% off home-country prices.

Where Panya fits

Our quiz routes based on your region and budget signal. If you are in the US with no insurance coverage, we route you to a compounded telehealth service with good COA/cold-chain practice. If you are in Thailand, we route you to a Bangkok clinic that passes our 11-signal rubric. If you are in Norway, we do not route research-chem at all and instead surface the EEA cross-border options.

Take the quiz and we email the specific match within 48 hours.

---

Citations: Panya internal vendor price survey, April 2026 (Thailand clinics, 12 reviewed); US compounded telehealth prices scraped April 2026 from public rate cards (Ro, Henry Meds, Mochi, LifeMD); Boots UK, Pharmacy2U, LloydsPharmacy Online Doctor public rates; European Medicines Agency price disclosures where available; government-published pharmacy pricing (NOR, SWE, DNK apotek networks).